Heron Therapeutics Inc (HRTX)
$0.28 -5.67% Close Oct 30, 2026 Live
Heron Therapeutics stock today
Heron Therapeutics closed at $0.28 on October 30, 2026, down 5.67% on the day. Over the past year it returned -75.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $53.0 million.
$0.50$1.00$1.50
NovJan 2026MarMayJulSep
| Period | HRTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -11.4% | -0.9% |
| 3 months | -44.2% | +2.1% |
| Year to date | -78.6% | +11.7% |
| 1 year | -75.6% | +12.4% |
| 3 years | -55.9% | +88.5% |
| 5 years | -97.5% | +76.0% |
Key statistics
- Market value
- $53.0M
- Price / sales
- 0.4
- 52-week range
- $0.27 to $1.49
- Next report
- Nov 9, 2026
About Heron Therapeutics
Develops pharmaceutical products for pain management and supportive care.
Sector: Health Care
More on Heron Therapeutics
- Financials: revenue, earnings and segmentsRevenue +7% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $18.33 today
No forecast, no recommendation. This page describes Heron Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.